Evidence map›Paper›PMID 41810003›Full record

ReviewInternational journal of nanomedicine2026

Iron Oxide-Based Magnetic Nanoparticles in Oral Infection Control.

Cai Yang, Xiubo Yang, Jinmiao Sun, Jiaxin Ding, Jiayue Guo, Shuang Liang, Min Wang

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cai YangDepartment of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.ORCID 0009-0005-1104-9939
Xiubo YangDepartment of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
Jinmiao SunDepartment of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
Jiaxin DingDepartment of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
Jiayue GuoDepartment of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
Shuang LiangDepartment of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
Min WangDepartment of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.ORCID 0000-0003-2142-2125

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In oral infectious diseases, recalcitrant biofilms, escalating antibiotic resistance, and limitations of local drug delivery within complex anatomical microenvironments necessitate innovative strategies for effective and precise therapy. Among magnetic nanoparticles (MNPs), iron oxide-based nanoparticles (IONPs) have attracted considerable attention in the management of oral infectious diseases because of their unique physicochemical features, including magnetic responsiveness, tunable morphology, and favorable biocompatibility. These properties enable MNPs to exert multimodal antibacterial effects, such as biofilm disruption, magnetothermal therapy, and reactive oxygen species (ROS)-mediated bactericidal activity, thereby allowing them to adaptively target and act within the anatomically constrained, biofilm-rich infection sites of the oral cavity. Recent advances have further explored their applications in caries, endodontic and periapical infections, periodontitis, peri-implantitis, and osteomyelitis of the jaw, highlighting their potential to overcome the limitations of conventional antibiotics. MNPs also enable rapid detection of oral pathogens via magnetic enrichment and point-of-care platforms, complementing their therapeutic potential. Key challenges include complex oral microenvironment interference, uncertain long-term biocompatibility, and obstacles to clinical translation. Future directions focus on omics-guided optimization, theranostic platforms integrating imaging and targeted therapy, and microbiota-modulating strategies. This review provides a comprehensive overview of the antibacterial mechanisms, therapeutic applications, and emerging multifunctional platforms of MNPs in oral infection control, while highlighting their translational potential and supporting their advancement toward safe and effective clinical applications.

Indexed as

Anti-Bacterial AgentsMagnetic Iron Oxide NanoparticlesMagnetite NanoparticlesMouth DiseasesAnimalsBiofilmsHumansAnti-Bacterial AgentsMagnetite Nanoparticlesantibacterialbiofilmsiron oxide nanoparticlesmagnetic nanoparticlesoral infections

Identifiers

PMID41810003
PMCPMC12968824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.